Business & Finance
Selvita acquires Fidelta
5 January 2021 -

Poland-based preclinical Contract Research Organisation Selvita SA (WSE: SLV) has completed the acquisition of Fidelta, also a contract research organisation, from Belgium-based Galapagos NV (Euronext &NASDAQ: GLPG), it was reported on Monday.

Selvita SA has acquired 100% of the outstanding shares in Fidelta. The deal is valued at EUR31.2m and the customary adjustments for net cash and working capital.

The acquisition should almost double Selvita's revenues. Fidelta will now be completely consolidated under the Selvita Group, but it will continue to operate under the Fidelta name.